CVS Health Q3 GAAP EPS $0.07, Adjusted EPS $1.09; records $1.1B premium deficiency reserve

CVS HEALTH Corp

2024-Q3 EPS reported $2.35 revenue$275,099,000,000

Total revenues $95.4B (+6.3% YoY); GAAP diluted EPS $0.07 vs $1.75 prior year.
Adjusted EPS $1.09 vs $2.21 prior year; operating income $832M down from $3.69B.
Health Care Benefits segment recorded ~$1.1B premium deficiency reserves ($0.63/share) for Medicare and individual exchange.
Year-to-date cash flow from operations $7.2B; CEO highlights strong Health Services and Pharmacy segments but challenges in Health Care Benefits.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.